Predictive immune markers in advanced melanoma patients treated with ipilimumab

Viktor Umansky1, Jochen Utikal1, Christoffer Gebhardt1

  • 1Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg and Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg , Heidelberg, Germany.

Oncoimmunology
|July 30, 2016
PubMed

Related Concept Videos